RECENT NEWS

Handa Oncology Receives FDA Tentative Approval for OMCAZIO (cabozantinib) Capsules

2026-08-04

Handa Therapeutics Acquires FDA Approved Chronic Myeloid Leukemia Drug, PHYRAGO (dasatinib) Tablets

2025-01-15